Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 6/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL652856 | 0.87 | CCR1 (0.59) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL10287629 | 0.87 | CCR1 (0.59) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL652857 | 0.87 | CCR1 (0.59) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL14579823 | 0.87 | CCR1 (0.59) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL654241 | 0.83 | CCR1 (0.60) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL654240 | 0.83 | CCR1 (0.60) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL654835 | 0.81 | CCR1 (0.58) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL14420168 | 0.81 | CCR1 (0.58) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL13617528 | 0.81 | CCR1 (0.57) | CCR1CHRM2CCR5HRH1ADRA1D | |
| SCHEMBL653647 | 0.81 | CCR1 (0.57) | CCR1CHRM2CCR5HRH1ADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541365-B2 | Chemokine receptor antagonists and methods of use therefor | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-06-02 | — | — | US | disclosed |